|
|
||||||||||
|
J Am Coll Cardiol, 1986; 8:436-440 © 1986 by the American College of Cardiology Foundation |
A patient who developed severe iron overload cardiomyopathy is described. Venesection could not be performed because the patient had chronic anemia. Deferoxamine mesylate, a chelating agent, was administered daily for more than 2 years and produced significant improvement in ventricular function which was associated with a biopsy-proven decrease in myocardial iron stores. This is the first reported case in which a severe cardiomyopathy due to iron overload was reversed by chelation therapy alone.
This article has been cited by other articles:
![]() |
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology Eur. Heart J., December 2, 2007; 28(24): 3076 - 3093. [Full Text] [PDF] |
||||
![]() |
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al. The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1914 - 1931. [Full Text] [PDF] |
||||
![]() |
L. T. Cooper, K. L. Baughman, A. M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G. N. Levine, J. Narula, R. C. Starling, J. Towbin, et al. The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Circulation, November 6, 2007; 116(19): 2216 - 2233. [Full Text] [PDF] |
||||
![]() |
Z. J. Wang, L. Lian, Q. Chen, H. Zhao, T. Asakura, and A. R. Cohen 1/T2 and Magnetic Susceptibility Measurements in a Gerbil Cardiac Iron Overload Model Radiology, March 1, 2005; 234(3): 749 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Walker The heart in thalassaemia Eur. Heart J., January 2, 2002; 23(2): 102 - 105. [Full Text] [PDF] |
||||
![]() |
W. J. Bartfay, F. Dawood, W. H. Wen, D. C. Lehotay, D. Hou, E. Bartfay, X. Luo, P. H. Backx, and P. P. Liu Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload Cardiovasc Res, September 1, 1999; 43(4): 892 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gore and J. T. Fallon Case 31-1994- A 25-Year-Old Man with the Recent Onset of Diabetes Mellitus and Congestive Heart Failure N. Engl. J. Med., August 18, 1994; 331(7): 460 - 466. [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |